ESC 2026 Highlights Clinical Implications of Prevention and Geriatric Trials
Audio narration · Coming soon
The late-breaking trials presented at ESC 2026 focused on prevention strategies spanning from healthy older adults to patients with atrial fibrillation (AFib) or acute coronary syndrome (ACS). These findings provide important clinical implications for managing cardiovascular health in the elderly population.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews
